市场调查报告书
商品编码
1497542
骨质密度检测设备市场:按类型、应用和最终用户划分 - 全球预测 2024-2030Bone Densitometer Market by Type (Axial Bone Densitometry, Dual-energy X-Ray Absorptiometry, Peripheral Bone Densitometry), Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年骨质密度检测设备市场规模为3.2287亿美元,预计2024年将达3.3807亿美元,2030年将达4.4807亿美元,复合年增长率为4.79%。
骨质密度检测设备主要由可用于评估骨骼密度、诊断骨质疏鬆症和评估个人骨折风险的设备组成。这些设备利用多种技术,包括双能量 X 射线检测法(DXA)、超音波和定量电脑断层扫描 (QCT),来量化骨矿物质含量并提供有关骨骼健康的资讯。由于世界人口老化、骨质疏鬆症盛行率增加以及患者对早期诊断和预防措施的认识不断提高,世界各地对骨质密度检测设备的需求不断增加。然而,该产品成本高昂,加上骨质密度检测设备结果存在误差,限制了其普及。此外,政府核准新开发的产品系列的严格核准程序对骨质密度检测设备的可用性产生了负面影响。市场参与企业对研发的大量投资以及先进骨质密度检测设备的出现预计将为未来几年骨质密度检测设备市场提供成长机会。
主要市场统计 | |
---|---|
基准年[2023] | 3.2287亿美元 |
预测年份 [2024] | 33807万美元 |
预测年份 [2030] | 44807万美元 |
复合年增长率(%) | 4.79% |
区域洞察
骨质密度检测设备市场在北美和南美不断增长,主要是在美国和加拿大等新兴市场,由于人们对骨骼健康意识的提高和整形外科疾病发病率的增加,对骨质密度检测设备的需求很高。此外,研究进展在推动市场成长方面也发挥着重要作用。在欧盟地区,骨质疏鬆症诊断和护理管理的趋势正在推动骨质密度检测设备设备的采用率。此外,促进预防性医疗措施的公共卫生计画也对欧盟国家的市场成长做出了重大贡献。然而,在中东和非洲地区,对医疗基础设施的策略性投资和对预防性医疗保健的日益关注预计将在未来几年促进市场成长。亚太地区骨质密度检测设备市场正在成长,主要由中国、日本和印度推动。这些国家人口老化严重,面临骨质疏鬆症和其他相关疾病的风险。由于人们对骨骼健康问题的宣导活动不断增强,对 DXA 系统等可携式设备的需求不断增长。此外,政府促进诊断技术研究的措施也对该地区的市场扩张产生了重大影响。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在骨质密度检测设备市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对骨质密度检测设备市场供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外,该分析还提供了对该细分市场竞争力的宝贵见解,包括研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前在骨质密度检测设备市场中的地位进行全面评估,使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[191 Pages Report] The Bone Densitometer Market size was estimated at USD 322.87 million in 2023 and expected to reach USD 338.07 million in 2024, at a CAGR 4.79% to reach USD 448.07 million by 2030.
The bone densitometer comprises devices that primarily help assess bone density, diagnose osteoporosis, and evaluate the risk of fracture in individuals. These devices utilize various technologies such as Dual-Energy X-ray Absorptiometry (DXA), ultrasound, and quantitative computed tomography (QCT) to quantify bone mineral content and accurately assess bone health. An aging global population, increasing prevalence of osteoporosis, and rising awareness about early diagnosis and prevention measures among patients have increased the need for bone densitometers worldwide. However, the high costs of products coupled with errors associated with the results of bone densitometers limit product penetration. In addition, the strict government approval procedures to approve newly developed product portfolios negatively impact the availability of bone densitometers. The significant investments by the market players in research and development and the emergence of advanced bone densitometers are expected to create growth opportunities for the bone densitometer market in the coming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 322.87 million |
Estimated Year [2024] | USD 338.07 million |
Forecast Year [2030] | USD 448.07 million |
CAGR (%) | 4.79% |
Regional Insights
The bone densitometer market is witnessing growth across the Americas, particularly in developed markets such as the United States and Canada, owing to high demand for bone densitometers due to increasing awareness about bone health and greater incidence of orthopedic conditions. Further, advances in research have also played a significant role in driving market growth. In the EU region, trends regarding osteoporosis diagnosis and care management initiatives have driven adoption rates for bone densitometer devices. Additionally, public health programs promoting preventative care measures contribute significantly to market growth in EU countries. However, with strategic investments in healthcare infrastructure and increasing focus on preventive care across the Middle East and Africa region, market growth is expected to grow in the coming years. The Asia-Pacific region is experiencing growth in the bone densitometer market, driven mainly by China, Japan, and India. These countries have a large aging population at risk for developing osteoporosis and other related conditions. The growing demand for portable devices such as DXA systems has resulted from increased awareness campaigns regarding bone health issues. Furthermore, government initiatives promoting research into diagnostic technologies have significantly impacted this market's expansion within this region.
Market Insights
The market dynamics represent an ever-changing landscape of the Bone Densitometer Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bone Densitometer Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bone Densitometer Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Fujitsu and iSurgery launched a bone health promotion project in Japan with Jikei University School of Medicine aiming for the early detection of osteoporosis
Fujitsu Limited and iSurgery Co., Ltd. are collaborating with the Department of Orthopaedic Surgery at Jikei University School of Medicine to conduct a field trial of their "bone health promotion project" from October 2023 to March 2025. This project aims to focus on employee bone health during examinations by utilizing chest radiographs in a novel way. The project group will utilize iSurgery's AI medical device, Chest Bone Indicator, to assess bone health from chest radiographs and inform staff members of their examination results. [Published On: 2023-09-26]
AFFIDEA Expands In Italy Through The Acquisition Of Istituto Radiologico Gandini
Affidea, a provider of diagnostic imaging, out-of-hospital, and cancer care services, has recently acquired Istituto Radiologico Gandini in Biella, Piedmont. Istituto Radiologico Gandini is renowned for its advanced diagnostic imaging services, particularly radiology and senology. The medical facility offers various innovative diagnostic technologies, including MRI, mammography, Bone Densitometry, Doppler ultrasound, and comprehensive breast check-ups. This acquisition further strengthens Affidea's commitment to delivering patients high-quality and cutting-edge diagnostic services. [Published On: 2023-05-05]
Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea's Leading Bone Densitometry Platform
MEDIMAPS GROUP, a Swiss-global med-tech company specializing in image processing software for bone health assessment, has made their Trabecular Bone Score (TBS iNsight) available on OsteoSys Co. Ltd's diagnostic platforms. OsteoSys, the Bone Mineral Densitometer brand in Korea and supplier of DXA scanning equipment worldwide, now offers TBS iNsight on their high-end DXA scanning product, Primus Whole Body DXA. This partnership aims to expand access to Medimaps' innovative technology to clinicians worldwide, including countries throughout Southeast Asia, Europe, and South America. [Published On: 2022-11-14]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bone Densitometer Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Bone Densitometer Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment, BeamMed, Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, Eurotec Systems S.r.l, FURUNO Electric Co., Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Intermedical Co.,Ltd., KWIPPED, Inc., L'acn L'accessorio Nucleare S.R.L, M-cast Inc., Medilink International Ltd., Medonica Co., Ltd., mpall Co., Ltd., Nanjing Kejin Industrial Co., Ltd., Nanoomtech Co., Ltd., Oscare Medical Oy, Osteosys Corporation, Scanflex Healthcare AB, Shenzhen XRAY Electric Co., Ltd., Swissray International, Inc., Trivitron Healthcare, Xianyang Kanrota Digital Ultrasound System, Co., Ltd., and YOZMA BMTech Co., Ltd..
Market Segmentation & Coverage